Highlights in Movement Disorders From the 2026 AMDAPP Conference: Erin Zinn, MSN, APRN-CNP, ANP-BC, CMRD

WATCH TIME: 5 minutes | Captions are auto-generated and may contain errors.

"It’s a really exciting time in movement disorders right now. There’s a lot of research going on, and it just feels like the field is moving forward in a meaningful way. It’s not just exciting for us as clinicians; it’s exciting for our patients too. I think research definitely is one of the exciting fronts."

The 2026 Association of Movement Disorder Advanced Practice Providers (AMDAPP) conference, held February 20-22, in Charleston, South Carolina, offered a comprehensive clinical review of movement disorders across its 2-day program. On Day 1, experts addressed neuroimaging in movement disorders, with a focus on dopamine transporter scanning, atypical Parkinsonism, normal pressure hydrocephalus, and deep brain stimulation infection. Subsequent sessions examined atypical Parkinsonism in the context of current clinical guidelines and ongoing trials, followed by updates on hyperkinetic disorders and nonmotor symptoms of Parkinson disease (PD).

Day 2 of the conference continued with focused sessions on autonomic and peripheral nervous system involvement in PD, exploring the diagnosis and management of dysautonomia and neuropathy. Experts then examined the evolving conceptualization of PD as a spectrum disorder, broadening the clinical framework beyond motor manifestations. The conference concluded with a wrap-up and evaluation session, reinforcing the program's emphasis on translating current evidence into advanced practice across the spectrum of movement disorder care.

In a recent interview with NeurologyLive^®, Erin Zinn, MSN, APRN-CNP, ANP-BC, CMRD, deputy director at AMDAPP, reflected on her experience at the conference from both a clinical and leadership perspective. She highlighted the relevance of sessions, particularly those focused on environmental factors in PD, neuroimaging, and DBS neuroanatomy. Beyond education, she underscored the importance of fostering connections through unique activities. Zinn also pointed to meaningful advancements in movement disorders, especially the growing role of subcutaneous pump therapies and device-based treatments, which are improving patient care.